These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3486448)

  • 21. [HLA antigens and side effects of gold and D-penicillamine in chronic polyarthritis].
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb N
    Wien Klin Wochenschr Suppl; 1984; 156():51-2. PubMed ID: 6442059
    [No Abstract]   [Full Text] [Related]  

  • 22. [Early recognition of adverse effects, especially of kidney lesions, in patients with progressive chronic polyarthritis under D-Penicillamine therapy].
    Otto W; Pietruschka WD; Beenken O
    Z Gesamte Inn Med; 1975 Aug; 30(15):507-9. PubMed ID: 1189496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complications of D-penicillamine treatment of rheumatoid poly-arthritis].
    Camus JP; Crouzet J; Prier A; Leca AP
    Therapie; 1976; 31(3):385-97. PubMed ID: 136767
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical rheumatoid vasculitis associated with the B8 DR3 phenotype.
    Cunningham TJ; Tait BD; Mathews JD; Muirden KD
    Rheumatol Int; 1982; 2(3):137-9. PubMed ID: 6984537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gold induced thrombocytopenia: platelet associated IgG and HLA typing in three patients.
    Adachi JD; Bensen WG; Singal DP; Powers PJ
    J Rheumatol; 1984 Jun; 11(3):355-7. PubMed ID: 6610758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histologic findings in siblings with acute sarcoid arthritis: association with the B8,DR3 phenotype.
    Kremer JM
    J Rheumatol; 1986 Jun; 13(3):593-7. PubMed ID: 3488404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Side effects of d-penicillamine in the treatment of rheumatoid arthritis].
    Mazzanti G; Paladini G; Damiani D; Bianchini D; Florean M; Mesesnel E; Cataldo R
    Minerva Med; 1986 May; 77(22-23):1009-16. PubMed ID: 2941698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody to rheumatoid arthritis associated nuclear antigen (RANA) in familial rheumatoid arthritis.
    Bell DA; Alspaugh MA
    J Rheumatol; 1984 Jun; 11(3):277-81. PubMed ID: 6610751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dermatopolymyositis induced by D-penicillamine in rheumatoid polyarthritis. Apropos of 1 case with review of the literature].
    Kolsi R; Bahloul Z; Hachicha J; Gouiaa R; Jarraya A
    Rev Rhum Mal Osteoartic; 1992 May; 59(5):341-4. PubMed ID: 1411195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myasthenia induced by D-penicillamine during the treatment of rheumatoid polyarthritis].
    Carter H; Job-Deslandre C; Delrieu F; Kahan A; Menkès CJ
    Rev Rhum Mal Osteoartic; 1986 May; 53(5):341-4. PubMed ID: 3738397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penicillamine nephropathy.
    Hall CL
    BMJ; 1988 Jul; 297(6641):137. PubMed ID: 3408946
    [No Abstract]   [Full Text] [Related]  

  • 32. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex.
    Bell DA; Rigby R; Stiller CR; Clark WF; Harth M; Ebers G
    J Rheumatol; 1984 Aug; 11(4):475-9. PubMed ID: 6332909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-penicillamine-induced polymyositis occurring in patients with rheumatoid arthritis: a report of two cases and demonstration of a positive lymphocyte stimulation test to D-penicillamine.
    Matsumura T; Yuhara T; Yamane K; Kono I; Kabashima T; Kashiwagi H
    Henry Ford Hosp Med J; 1986; 34(2):123-6. PubMed ID: 3489699
    [No Abstract]   [Full Text] [Related]  

  • 34. Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HLA-B8/DR3.
    Amer A; Singh G; Darke C; Dolby AE
    Tissue Antigens; 1986 Oct; 28(4):193-8. PubMed ID: 3492778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexistence of HLA-B27 ankylosing spondylitis and DR4 seropositive nodular rheumatoid arthritis in patient with membranous nephropathy.
    Lemmer JP; Irby WR
    J Rheumatol; 1981; 8(4):661-4. PubMed ID: 6975378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of rheumatoid arthritis using D-penicillamine].
    Ott VR; Schmidt KL
    Internist (Berl); 1974 Jun; 15(6):328-35. PubMed ID: 4211090
    [No Abstract]   [Full Text] [Related]  

  • 37. Natural course of penicillamine nephropathy: a long term study of 33 patients.
    Hall CL; Jawad S; Harrison PR; MacKenzie JC; Bacon PA; Klouda PT; MacIver AG
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1083-6. PubMed ID: 3132218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature.
    Honkanen E; Törnroth T; Pettersson E; Skrifvars B
    Clin Nephrol; 1987 Feb; 27(2):87-93. PubMed ID: 3829481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis.
    Devogelaer JP; Isaac G; Noël H; De Bruyère M; Huaux JP; Nagant de Deuxchaisnes C
    Int J Clin Pharmacol Res; 1985; 5(3):143-7. PubMed ID: 4018948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.
    Delamere JP; Jobson S; Mackintosh LP; Wells L; Walton KW
    Ann Rheum Dis; 1983 Oct; 42(5):500-4. PubMed ID: 6605118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.